Technical Analysis for PLX - Protalix BioTherapeutics, Inc.

Grade Last Price % Change Price Change
grade F 0.396 -0.75% 0.00
PLX closed down 0.75 percent on Monday, May 20, 2019, on 64 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical PLX trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
20 DMA Resistance Bearish -0.75%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.75%
Lower Bollinger Band Walk Weakness -0.75%
BB Squeeze Ended Range Expansion -0.75%
Outside Day Range Expansion -0.75%
Lower Bollinger Band Touch Weakness -0.75%

Older signals for PLX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Protalix BioTherapeutics, Inc., a biopharmaceutical company, together with its subsidiary, Protalix Ltd., focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system. It offers taliglucerase alfa for injection, which is marketed under the ELELYSO brand name, as an enzyme replacement therapy for the long-term treatment of adult patients with a confirmed diagnosis of type 1 Gaucher disease. The company's product pipeline includes PRX-102, a therapeutic protein candidate for the treatment of Fabry disease; PRX-105, a plant cell expressed pegylated recombinant acetylcholinesterase product candidate for biodefense and other indications; and an orally-administered glucocerebrosidase enzyme for the treatment of Gaucher patients utilizing oral delivery of the recombinant enzyme produced within carrot cells. Its product pipeline also comprises PRX-106 or pr-antiTNF, a plant cell expressed recombinant fusion protein made from the soluble form of the human TNF receptor and an antibody portion, which is being developed as a treatment of certain immune diseases, such as rheumatoid arthritis, Chrohn's disease, placque psoriasis, and other autoimmune disorders; and two additional undisclosed therapeutic proteins that are being evaluated in animal studies. It has a collaboration and licensing agreement with Teva Pharmaceutical Industries Ltd. to develop and manufacture two proteins using its ProCellEx protein expression system. The company was founded in 1993 and is based in Carmiel, Israel.
Biotechnology Biopharmaceutical Life Sciences Biology Rheumatoid Arthritis Autoimmune Disorders Enzyme Replacement Therapy Fabry Disease Gaucher Disease Recombinant Dna Treatment Of Fabry Disease
Is PLX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 0.83
52 Week Low 0.27
Average Volume 313,540
200-Day Moving Average 0.469
50-Day Moving Average 0.4335
20-Day Moving Average 0.4157
10-Day Moving Average 0.4068
Average True Range 0.0267
ADX 18.94
+DI 9.3523
-DI 14.5929
Chandelier Exit (Long, 3 ATRs ) 0.3642
Chandelier Exit (Short, 3 ATRs ) 0.4702
Upper Bollinger Band 0.4409
Lower Bollinger Band 0.3905
Percent B (%b) 0.11
BandWidth 12.124128
MACD Line -0.0093
MACD Signal Line -0.0081
MACD Histogram -0.0012
Fundamentals Value
Market Cap 52.81 Million
Num Shares 133 Million
EPS -0.60
Price-to-Earnings (P/E) Ratio -0.66
Price-to-Sales 6.07
Price-to-Book 0.00
PEG Ratio -0.16
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.41
Resistance 3 (R3) 0.41 0.41 0.41
Resistance 2 (R2) 0.41 0.40 0.41 0.41
Resistance 1 (R1) 0.40 0.40 0.41 0.40 0.41
Pivot Point 0.40 0.40 0.40 0.40 0.40
Support 1 (S1) 0.39 0.39 0.39 0.39 0.38
Support 2 (S2) 0.38 0.39 0.38 0.38
Support 3 (S3) 0.38 0.38 0.38
Support 4 (S4) 0.38